Jacques Dessureault
Chairman chez Optina Diagnostics, Inc.
Fortune : 2 331 $ au 31/03/2024
Profil
Jacques Dessureault is currently the Chairman at Optina Diagnostics, Inc. He previously held positions as the President & Director at Valeant Canada Ltd.
from 2012 to 2017, Lead Independent Director at BZAM Ltd.
from 2019 to 2023, President & General Manager at Bausch Health Americas, Inc., Head-Global Marketing Division at Novartis AG, President & General Manager at Bausch Health Cos., Inc., Vice President at Bristol-Myers Squibb Canada Co., and General Manager & Head-Business Unit at Novartis Pharma Canada, Inc. Mr. Dessureault has a graduate degree from the University of Leicester and an undergraduate degree from École Des Sciences De La Gestion.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
BZAM LTD
0,03% | 25/11/2022 | 63 003 ( 0,03% ) | 2 331 $ | 31/03/2024 |
Postes actifs de Jacques Dessureault
| Sociétés | Poste | Début |
|---|---|---|
Optina Diagnostics, Inc.
 Optina Diagnostics, Inc. Medical SpecialtiesHealth Technology Optina Diagnostics, Inc. manufactures retinal diagnostic imaging devices to detect alzheimer's diseases. The company is headquartered in Montréal, Canada. | Chairman | - |
Anciens postes connus de Jacques Dessureault
| Sociétés | Poste | Fin |
|---|---|---|
| BZAM LTD. | Director/Board Member | 28/04/2023 |
Valeant Canada Ltd.
 Valeant Canada Ltd. Pharmaceuticals: MajorHealth Technology Valeant Canada Ltd. manufactures and distributes pharmaceutical products to both primary care and physicians in Canada. The firm focuses its efforts primarily in the areas of pain management, cardiovascular disease, neurology and dermatology. The company was founded in 1956 and is headquartered in Laval, Canada. | President | 01/06/2017 |
| Novartis Pharma Canada, Inc. | Corporate Officer/Principal | - |
Bausch Health Americas, Inc.
 Bausch Health Americas, Inc. Pharmaceuticals: MajorHealth Technology Bausch Health Americas, Inc. manufactures and distributes pharmaceutical products. The company was founded on November 29, 2011 and is headquartered in Bridgewater, NJ. | President | - |
| NOVARTIS AG | Sales & Marketing | - |
Formation de Jacques Dessureault
| University of Leicester | Graduate Degree |
| École Des Sciences De La Gestion | Undergraduate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| NOVARTIS AG | Health Technology |
| BAUSCH HEALTH COMPANIES INC. | Health Technology |
| BZAM LTD. | Process Industries |
| Entreprise privées | 5 |
|---|---|
Bausch Health Americas, Inc.
Bausch Health Americas, Inc. Pharmaceuticals: MajorHealth Technology Bausch Health Americas, Inc. manufactures and distributes pharmaceutical products. The company was founded on November 29, 2011 and is headquartered in Bridgewater, NJ. | Health Technology |
Valeant Canada Ltd.
Valeant Canada Ltd. Pharmaceuticals: MajorHealth Technology Valeant Canada Ltd. manufactures and distributes pharmaceutical products to both primary care and physicians in Canada. The firm focuses its efforts primarily in the areas of pain management, cardiovascular disease, neurology and dermatology. The company was founded in 1956 and is headquartered in Laval, Canada. | Health Technology |
Bristol-Myers Squibb Canada Co.
 Bristol-Myers Squibb Canada Co. Pharmaceuticals: MajorHealth Technology Bristol-Myers Squibb Canada Co. designs, develops and wholesales pharmaceutical products. The company is headquartered in Halifax, Canada. | Health Technology |
| Novartis Pharma Canada, Inc. | |
Optina Diagnostics, Inc.
Optina Diagnostics, Inc. Medical SpecialtiesHealth Technology Optina Diagnostics, Inc. manufactures retinal diagnostic imaging devices to detect alzheimer's diseases. The company is headquartered in Montréal, Canada. | Health Technology |
